PHARMATARGETS

Serial Number 76081607
Registration 2818656
710

Registration Progress

Application Filed
Jun 28, 2000
Under Examination
Approved for Publication
Nov 19, 2003
Published for Opposition
Dec 9, 2003
Registered
Mar 2, 2004

Trademark Image

PHARMATARGETS

Basic Information

Serial Number
76081607
Registration Number
2818656
Filing Date
June 28, 2000
Registration Date
March 2, 2004
Published for Opposition
December 9, 2003
Cancellation Date
October 8, 2010
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Oct 8, 2010

Rights Holder

Mermaid Pharmaceuticals GmbH

03
Address
Lagerstr. 1
20357 Hamburg
DE

Ownership History

Mermaid Pharmaceuticals GmbH

Original Applicant
03
20357 Hamburg DE

Mermaid Pharmaceuticals GmbH

Owner at Publication
03
20357 Hamburg DE

Mermaid Pharmaceuticals GmbH

Original Registrant
03
20357 Hamburg DE

Legal Representation

Attorney
PETER F. CORLESS

USPTO Deadlines

Next Deadline
3133 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2004-03-02)
Due Date
March 02, 2034
Grace Period Ends
September 02, 2034

Application History

14 events
Date Code Type Description Documents
Oct 8, 2010 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Jun 6, 2007 CFIT O CASE FILE IN TICRS Loading...
Mar 2, 2004 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 9, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Oct 15, 2003 44DD I SEC. 44(D) CLAIM DELETED Loading...
Jan 27, 2003 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 4, 2002 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 10, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 29, 2001 CNFR O FINAL REFUSAL MAILED Loading...
May 29, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 4, 2000 CNRT F NON-FINAL ACTION MAILED Loading...
Nov 28, 2000 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 22, 2000 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...

Additional Information

Pseudo Mark
PHARMA TARGETS